Global Vascular株式会社
Tokyo, JP · 5 known investors
Global Vascular develops medical devices based on its BioDiamond Technology, including antithrombotic diamond (F-DLC) coatings, drug-eluting stents, and catheters for vascular and interventional treatments. The company emerged from a medical-engineering research collaboration between Keio University and Tokai University in Japan.
Founders & leadership
Board
TH
Terumitsu HasebeBoard director
Investors · 5
Competitors · 1
by search overlap
Companies competing with Global Vascular株式会社 for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Global Vascular株式会社 do?
- Global Vascular develops medical devices based on its BioDiamond Technology, including antithrombotic diamond (F-DLC) coatings, drug-eluting stents, and catheters for vascular and interventional treatments. The company emerged from a medical-engineering research collaboration between Keio University and Tokai University in Japan.
- Who founded Global Vascular株式会社?
- Global Vascular株式会社 was founded by Kenta Bito, Shunto Maegawa.
- Who are Global Vascular株式会社's investors?
- Global Vascular株式会社's investors include Fast Track Initiative, Tokyo University of Science Innovation Capital, Mitsubishi UFJ Capital, Mitsui Sumitomo Insurance Capital, Sumitomo Mitsui Trust Bank.
- Where is Global Vascular株式会社 headquartered?
- Global Vascular株式会社 is headquartered in Tokyo, JP.